Use of hormones and risk of venous thromboembolism
Authors:
- Venina Isabel Poço Viana Leme de BarrosVBVenina Isabel Poço Viana Leme de Barros
- André Luiz Malavasi Longo de OliveiraAOAndré Luiz Malavasi Longo de Oliveira
- Denis Jose Do NascimentoDNDenis Jose Do Nascimento
- Eduardo ZlotnikEZEduardo Zlotnik
- Marcelo Melzer TeruchkinMTMarcelo Melzer Teruchkin
- Marcos Arêas MarquesMarcos Arêas Marques
- Paulo Francisco Ramos MargaridoPMPaulo Francisco Ramos Margarido
Open Access
- 2 April 2024
- journal article
- research article
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 46
Abstract
Key points •The risk of venous thromboembolism (VTE) is not increased in women using long-acting reversible contraceptive methods (LARCs) with progestogens. •Oral contraceptives with levonorgestrel or norgestimate confer half the risk of VTE compared to oral contraceptives containing desogestrel, gestodene or drospirenone. •Progestogen-only pills do not confer an increased risk of VTE. •Women using transdermal […] Key points •The risk of venous thromboembolism (VTE) is not increased in women using long-acting reversible contraceptive methods (LARCs) with progestogens. •Oral contraceptives with levonorgestrel or norgestimate confer half the risk of VTE compared to oral contraceptives containing desogestrel, gestodene or drospirenone. •Progestogen-only pills do not confer an increased risk of VTE. •Women using transdermal […]Keywords
This publication has 38 references indexed in Scilit:
- Estrogen and thrombosis: A bench to bedside reviewThrombosis Research, 2020
- How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?Blood Reviews, 2017
- Progestin-only contraception and thromboembolism: A systematic reviewContraception, 2016
- Transgender people: health at the margins of societyThe Lancet, 2016
- Prevalence of Transgender Depends on the “Case” Definition: A Systematic ReviewThe Journal of Sexual Medicine, 2016
- Contraceptive failure in the United StatesContraception, 2011
- Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation “pill scare”Contraception, 2010
- The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observationContraception, 2007
- Evidence from randomised trials on the long-term effects of hormone replacement therapyThe Lancet, 2002
- Higher Risk of Venous Thrombosis During Early Use of Oral Contraceptives in Women With Inherited Clotting DefectsArchives of internal medicine (1960), 2000